世界の咽頭がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pharyngeal Cancer Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4705 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、咽頭がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（標的療法、化学療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・咽頭がん治療の市場動向 ・企業の競争状況、市場シェア ・咽頭がん治療の種類別市場規模と予測2016-2027（標的療法、化学療法） ・咽頭がん治療の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・咽頭がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・咽頭がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・咽頭がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・咽頭がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・咽頭がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca Plc、Bristol-Myers Squibb Co.、Eli Lilly and Co.、Roche、Merck & Co., Inc.、Mylan NV、Pfizer Inc.、Sanofi、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.） ・結論

Some of the significant risk factors for pharyngeal cancer include the extended use of tobacco, excessive alcohol consumption, increasing viral infections, and occupational hazards. Tobacco smoke contains carcinogens that can damage DNA and develop unusual cells leading to cancer.
Alcohol abuse and its combination with tobacco further increase the risk of developing pharyngeal cancer. Also, individuals exposed to certain chemicals, dust, and fumes in their working environments, such as high-dose radiation environments and wood, metal, leather, textile, and petroleum industries have high chances of developing pharyngeal cancer.

Market Analysis and Insights: Global Pharyngeal Cancer Therapeutics Market
The global Pharyngeal Cancer Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharyngeal Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharyngeal Cancer Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharyngeal Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharyngeal Cancer Therapeutics market.

Global Pharyngeal Cancer Therapeutics Scope and Market Size
Pharyngeal Cancer Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharyngeal Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Targeted Therapy
Chemotherapy

Segment by Application
Hospital
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca Plc
Bristol-Myers Squibb Co.
Eli Lilly and Co.
Roche
Merck & Co., Inc.
Mylan NV
Pfizer Inc.
Sanofi
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharyngeal Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Targeted Therapy
1.2.3 Chemotherapy
1.3 Market by Application
1.3.1 Global Pharyngeal Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pharyngeal Cancer Therapeutics Market Perspective (2016-2027)
2.2 Pharyngeal Cancer Therapeutics Growth Trends by Regions
2.2.1 Pharyngeal Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharyngeal Cancer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Pharyngeal Cancer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Pharyngeal Cancer Therapeutics Industry Dynamic
2.3.1 Pharyngeal Cancer Therapeutics Market Trends
2.3.2 Pharyngeal Cancer Therapeutics Market Drivers
2.3.3 Pharyngeal Cancer Therapeutics Market Challenges
2.3.4 Pharyngeal Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pharyngeal Cancer Therapeutics Players by Revenue
3.1.1 Global Top Pharyngeal Cancer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Pharyngeal Cancer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Pharyngeal Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharyngeal Cancer Therapeutics Revenue
3.4 Global Pharyngeal Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Pharyngeal Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharyngeal Cancer Therapeutics Revenue in 2020
3.5 Pharyngeal Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Pharyngeal Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Pharyngeal Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pharyngeal Cancer Therapeutics Breakdown Data by Type
4.1 Global Pharyngeal Cancer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Pharyngeal Cancer Therapeutics Forecasted Market Size by Type (2022-2027)

5 Pharyngeal Cancer Therapeutics Breakdown Data by Application
5.1 Global Pharyngeal Cancer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Pharyngeal Cancer Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pharyngeal Cancer Therapeutics Market Size (2016-2027)
6.2 North America Pharyngeal Cancer Therapeutics Market Size by Type
6.2.1 North America Pharyngeal Cancer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Pharyngeal Cancer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Pharyngeal Cancer Therapeutics Market Size by Type (2016-2027)
6.3 North America Pharyngeal Cancer Therapeutics Market Size by Application
6.3.1 North America Pharyngeal Cancer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Pharyngeal Cancer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Pharyngeal Cancer Therapeutics Market Size by Application (2016-2027)
6.4 North America Pharyngeal Cancer Therapeutics Market Size by Country
6.4.1 North America Pharyngeal Cancer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Pharyngeal Cancer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pharyngeal Cancer Therapeutics Market Size (2016-2027)
7.2 Europe Pharyngeal Cancer Therapeutics Market Size by Type
7.2.1 Europe Pharyngeal Cancer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Pharyngeal Cancer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Pharyngeal Cancer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Pharyngeal Cancer Therapeutics Market Size by Application
7.3.1 Europe Pharyngeal Cancer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Pharyngeal Cancer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Pharyngeal Cancer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Pharyngeal Cancer Therapeutics Market Size by Country
7.4.1 Europe Pharyngeal Cancer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Pharyngeal Cancer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pharyngeal Cancer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Pharyngeal Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Pharyngeal Cancer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pharyngeal Cancer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pharyngeal Cancer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Pharyngeal Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Pharyngeal Cancer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pharyngeal Cancer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pharyngeal Cancer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Pharyngeal Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Pharyngeal Cancer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharyngeal Cancer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pharyngeal Cancer Therapeutics Market Size (2016-2027)
9.2 Latin America Pharyngeal Cancer Therapeutics Market Size by Type
9.2.1 Latin America Pharyngeal Cancer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Pharyngeal Cancer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Pharyngeal Cancer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Pharyngeal Cancer Therapeutics Market Size by Application
9.3.1 Latin America Pharyngeal Cancer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Pharyngeal Cancer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Pharyngeal Cancer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Pharyngeal Cancer Therapeutics Market Size by Country
9.4.1 Latin America Pharyngeal Cancer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Pharyngeal Cancer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pharyngeal Cancer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Pharyngeal Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Pharyngeal Cancer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pharyngeal Cancer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pharyngeal Cancer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Pharyngeal Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Pharyngeal Cancer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pharyngeal Cancer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pharyngeal Cancer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Pharyngeal Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Pharyngeal Cancer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharyngeal Cancer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca Plc
11.1.1 AstraZeneca Plc Company Details
11.1.2 AstraZeneca Plc Business Overview
11.1.3 AstraZeneca Plc Pharyngeal Cancer Therapeutics Introduction
11.1.4 AstraZeneca Plc Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021)
11.1.5 AstraZeneca Plc Recent Development
11.2 Bristol-Myers Squibb Co.
11.2.1 Bristol-Myers Squibb Co. Company Details
11.2.2 Bristol-Myers Squibb Co. Business Overview
11.2.3 Bristol-Myers Squibb Co. Pharyngeal Cancer Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Co. Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021)
11.2.5 Bristol-Myers Squibb Co. Recent Development
11.3 Eli Lilly and Co.
11.3.1 Eli Lilly and Co. Company Details
11.3.2 Eli Lilly and Co. Business Overview
11.3.3 Eli Lilly and Co. Pharyngeal Cancer Therapeutics Introduction
11.3.4 Eli Lilly and Co. Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021)
11.3.5 Eli Lilly and Co. Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Pharyngeal Cancer Therapeutics Introduction
11.4.4 Roche Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Company Details
11.5.2 Merck & Co., Inc. Business Overview
11.5.3 Merck & Co., Inc. Pharyngeal Cancer Therapeutics Introduction
11.5.4 Merck & Co., Inc. Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021)
11.5.5 Merck & Co., Inc. Recent Development
11.6 Mylan NV
11.6.1 Mylan NV Company Details
11.6.2 Mylan NV Business Overview
11.6.3 Mylan NV Pharyngeal Cancer Therapeutics Introduction
11.6.4 Mylan NV Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021)
11.6.5 Mylan NV Recent Development
11.7 Pfizer Inc.
11.7.1 Pfizer Inc. Company Details
11.7.2 Pfizer Inc. Business Overview
11.7.3 Pfizer Inc. Pharyngeal Cancer Therapeutics Introduction
11.7.4 Pfizer Inc. Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021)
11.7.5 Pfizer Inc. Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Pharyngeal Cancer Therapeutics Introduction
11.8.4 Sanofi Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Sun Pharmaceutical Industries Ltd.
11.9.1 Sun Pharmaceutical Industries Ltd. Company Details
11.9.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.9.3 Sun Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Introduction
11.9.4 Sun Pharmaceutical Industries Ltd. Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021)
11.9.5 Sun Pharmaceutical Industries Ltd. Recent Development
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Company Details
11.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.10.3 Teva Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Introduction
11.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021)
11.10.5 Teva Pharmaceutical Industries Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pharyngeal Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Targeted Therapy
Table 3. Key Players of Chemotherapy
Table 4. Global Pharyngeal Cancer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Pharyngeal Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pharyngeal Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Pharyngeal Cancer Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Pharyngeal Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Pharyngeal Cancer Therapeutics Market Share by Regions (2022-2027)
Table 10. Pharyngeal Cancer Therapeutics Market Trends
Table 11. Pharyngeal Cancer Therapeutics Market Drivers
Table 12. Pharyngeal Cancer Therapeutics Market Challenges
Table 13. Pharyngeal Cancer Therapeutics Market Restraints
Table 14. Global Pharyngeal Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Pharyngeal Cancer Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Pharyngeal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharyngeal Cancer Therapeutics as of 2020)
Table 17. Ranking of Global Top Pharyngeal Cancer Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Pharyngeal Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pharyngeal Cancer Therapeutics Product Solution and Service
Table 21. Date of Enter into Pharyngeal Cancer Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharyngeal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Pharyngeal Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Pharyngeal Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Pharyngeal Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Pharyngeal Cancer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Pharyngeal Cancer Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Pharyngeal Cancer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Pharyngeal Cancer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Pharyngeal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Pharyngeal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Pharyngeal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Pharyngeal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Pharyngeal Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Pharyngeal Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Pharyngeal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Pharyngeal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Pharyngeal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Pharyngeal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Pharyngeal Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Pharyngeal Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Pharyngeal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Pharyngeal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pharyngeal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pharyngeal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pharyngeal Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Pharyngeal Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Pharyngeal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Pharyngeal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Pharyngeal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Pharyngeal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Pharyngeal Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Pharyngeal Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Pharyngeal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Pharyngeal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pharyngeal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pharyngeal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pharyngeal Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Pharyngeal Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. AstraZeneca Plc Company Details
Table 62. AstraZeneca Plc Business Overview
Table 63. AstraZeneca Plc Pharyngeal Cancer Therapeutics Product
Table 64. AstraZeneca Plc Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 65. AstraZeneca Plc Recent Development
Table 66. Bristol-Myers Squibb Co. Company Details
Table 67. Bristol-Myers Squibb Co. Business Overview
Table 68. Bristol-Myers Squibb Co. Pharyngeal Cancer Therapeutics Product
Table 69. Bristol-Myers Squibb Co. Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Bristol-Myers Squibb Co. Recent Development
Table 71. Eli Lilly and Co. Company Details
Table 72. Eli Lilly and Co. Business Overview
Table 73. Eli Lilly and Co. Pharyngeal Cancer Therapeutics Product
Table 74. Eli Lilly and Co. Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Eli Lilly and Co. Recent Development
Table 76. Roche Company Details
Table 77. Roche Business Overview
Table 78. Roche Pharyngeal Cancer Therapeutics Product
Table 79. Roche Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Roche Recent Development
Table 81. Merck & Co., Inc. Company Details
Table 82. Merck & Co., Inc. Business Overview
Table 83. Merck & Co., Inc. Pharyngeal Cancer Therapeutics Product
Table 84. Merck & Co., Inc. Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 85. Merck & Co., Inc. Recent Development
Table 86. Mylan NV Company Details
Table 87. Mylan NV Business Overview
Table 88. Mylan NV Pharyngeal Cancer Therapeutics Product
Table 89. Mylan NV Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Mylan NV Recent Development
Table 91. Pfizer Inc. Company Details
Table 92. Pfizer Inc. Business Overview
Table 93. Pfizer Inc. Pharyngeal Cancer Therapeutics Product
Table 94. Pfizer Inc. Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Pfizer Inc. Recent Development
Table 96. Sanofi Company Details
Table 97. Sanofi Business Overview
Table 98. Sanofi Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Sanofi Recent Development
Table 100. Sun Pharmaceutical Industries Ltd. Company Details
Table 101. Sun Pharmaceutical Industries Ltd. Business Overview
Table 102. Sun Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Product
Table 103. Sun Pharmaceutical Industries Ltd. Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Sun Pharmaceutical Industries Ltd. Recent Development
Table 105. Teva Pharmaceutical Industries Ltd. Company Details
Table 106. Teva Pharmaceutical Industries Ltd. Business Overview
Table 107. Teva Pharmaceutical Industries Ltd. Pharyngeal Cancer Therapeutics Product
Table 108. Teva Pharmaceutical Industries Ltd. Revenue in Pharyngeal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Teva Pharmaceutical Industries Ltd. Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharyngeal Cancer Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Targeted Therapy Features
Figure 3. Chemotherapy Features
Figure 4. Global Pharyngeal Cancer Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Other Case Studies
Figure 8. Pharyngeal Cancer Therapeutics Report Years Considered
Figure 9. Global Pharyngeal Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Pharyngeal Cancer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Pharyngeal Cancer Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Pharyngeal Cancer Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Pharyngeal Cancer Therapeutics Market Share by Players in 2020
Figure 14. Global Top Pharyngeal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharyngeal Cancer Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Pharyngeal Cancer Therapeutics Revenue in 2020
Figure 16. Global Pharyngeal Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Pharyngeal Cancer Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Pharyngeal Cancer Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Pharyngeal Cancer Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Pharyngeal Cancer Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pharyngeal Cancer Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Pharyngeal Cancer Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Pharyngeal Cancer Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pharyngeal Cancer Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Pharyngeal Cancer Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Pharyngeal Cancer Therapeutics Market Share by Region (2016-2027)
Figure 38. China Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pharyngeal Cancer Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Pharyngeal Cancer Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Pharyngeal Cancer Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pharyngeal Cancer Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Pharyngeal Cancer Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Pharyngeal Cancer Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Pharyngeal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AstraZeneca Plc Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2016-2021)
Figure 58. Bristol-Myers Squibb Co. Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2016-2021)
Figure 59. Eli Lilly and Co. Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2016-2021)
Figure 61. Merck & Co., Inc. Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2016-2021)
Figure 62. Mylan NV Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2016-2021)
Figure 63. Pfizer Inc. Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2016-2021)
Figure 64. Sanofi Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2016-2021)
Figure 65. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2016-2021)
Figure 66. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Pharyngeal Cancer Therapeutics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---